WO2016160877A1
|
|
Non-enzymatic nucleic acid detection using an oligonucleotide linker with a large cell gap
|
US2017114392A1
|
|
Methods and devices for accurate diagnosis of infections
|
WO2016060917A2
|
|
Formulations for histatin therapeutics
|
WO2014137862A2
|
|
Detection of exposure to chemical warfare nerve agents with lateral flow assays
|
BR112015021317A2
|
|
lateral flow device for detecting an analyte in a sample, and method of operating a sample test on a lateral flow device
|
US2013296530A1
|
|
Use of peptides for promoting wound healing
|
US2013189709A1
|
|
Multiplanar Lateral Flow Assay with Sample Compressor
|
US2015004716A1
|
|
Detection of Exposure to Chemical Warfare Nerve Agents with Lateral Flow Assays
|
US2013196310A1
|
|
Method and Device for Combined Detection of Viral and Bacterial Infections
|
US2013196311A1
|
|
Method and device for combined detection of viral and bacterial infections
|
US2013230846A1
|
|
Multiplanar lateral flow assay with diverting zone
|
US2013344565A1
|
|
Optimization of Expression and Purification of Recombinant Human MxA Protein in E. Coli
|
US2013310326A1
|
|
Histatin for Corneal Wound Healing and Ocular Surface Disease
|
US2013130367A1
|
|
Method and device for combined detection of viral and bacterial infections
|
US2013017559A1
|
|
Lateral flow assays with time delayed components
|
WO2013016114A2
|
|
Enzymatic cleavage based lateral flow assays
|
AU2010325893A1
|
|
Multiplanar lateral flow assay with sample compressor
|
US2011086359A1
|
|
Lateral flow assays
|
EP2335072A2
|
|
Method and device for combined detection of viral and bacterial infections
|
EP2313527A2
|
|
Lateral flow nucleic acid detector
|